WO1993002055A1 - Process for producing quinolonecarboxylic acid derivative - Google Patents
Process for producing quinolonecarboxylic acid derivative Download PDFInfo
- Publication number
- WO1993002055A1 WO1993002055A1 PCT/JP1992/000901 JP9200901W WO9302055A1 WO 1993002055 A1 WO1993002055 A1 WO 1993002055A1 JP 9200901 W JP9200901 W JP 9200901W WO 9302055 A1 WO9302055 A1 WO 9302055A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- general formula
- substituted
- lower alkyl
- acid derivative
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract description 15
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical class C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 title description 2
- -1 6-fluoro-7-substituted quinolonecarboxylic acid Chemical class 0.000 claims abstract description 27
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 16
- 125000003282 alkyl amino group Chemical group 0.000 claims abstract description 13
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims abstract description 9
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 125000003277 amino group Chemical group 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000003107 substituted aryl group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- NHROTQIETDGGMP-UHFFFAOYSA-N 6-fluoro-2-oxo-1h-quinoline-3-carboxylic acid Chemical class FC1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 NHROTQIETDGGMP-UHFFFAOYSA-N 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 21
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical group C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000013078 crystal Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 238000010992 reflux Methods 0.000 description 6
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical group C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 5
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000009776 industrial production Methods 0.000 description 4
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 4
- 229910015900 BF3 Inorganic materials 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- IPLRIFOYICTCRM-UHFFFAOYSA-N 2-pyrrolidin-1-ylquinoline-3-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N=C1N1CCCC1 IPLRIFOYICTCRM-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- SPLNGOFULBNITO-UHFFFAOYSA-N O=C1C(C(O)=O)C=NC2=C1C=CC=C2OC Chemical compound O=C1C(C(O)=O)C=NC2=C1C=CC=C2OC SPLNGOFULBNITO-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical compound C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 1
- 229960002195 perazine Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0201—Oxygen-containing compounds
- B01J31/0211—Oxygen-containing compounds with a metal-oxygen link
- B01J31/0212—Alkoxylates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Definitions
- the present invention relates to a novel method for producing a quinolonecarboxylic acid derivative represented by the following general formula (4).
- R represents a lower alkyl group or a cyclic lower alkyl group
- R 2 represents a hydrogen atom, a halogen atom or a lower alkoxy group
- X represents —CH 2 —, NB 4 —, 10 —
- Y represents a hydrogen atom, an amino group or a lower alkylamino group bonded to any carbon atom on a saturated heterocyclic ring, or by a chemical means.
- the 6-fluoro-7-substituted quinolocarbonylcarboxylic acid derivative represented by the general formula (4) is a compound useful as a drug substance used as an antibacterial agent and as a synthetic intermediate thereof.
- a method for producing the compound a method in which a quinolone skeleton is formed after a specific substituent is first introduced into a benzene ring at a desired position, or a method in which a specific precursor is added at a desired position. After the introduction of a substituent, a quinolone ring is formed, and then a substituent serving as a precursor is identified. There is a method of converting to a certain substituent.
- R 2 represents a hydrogen atom, a halogen atom or a lower alkoxy group
- R 3 represents any function capable of participating in a nucleophilic substitution reaction.
- X represents CH 2 —, -R 0 —, represents a hydrogen atom or a lower alkyl group
- Y represents a hydrogen atom or an amino group bonded to any carbon atom on a saturated heterocyclic ring.
- the lower alkylamino group is a group which can be easily converted to an amino group or a lower alkylamino group by chemical means, and n represents 0 or 1).
- this reaction is carried out by reacting a compound represented by the general formula (1) Is heated in a solution (JP-A-62-252772, JP-A-64-16746) or a compound represented by the general formula (1) in order to facilitate the nucleophilic substitution reaction at the 7-position. )),
- the carboxyl group at the 3-position is converted into a hydrofluoroester, and after adding the compound represented by the general formula (2), the mixture is heated in a solution (JP-A-63-316757).
- a solution JP-A-63-316757
- the nucleophilicity differs depending on the kind of the amine represented by the general formula (2), so that the reactivity decreases, or the effect of a base added as an acceptor of an acid generated by the reaction is reduced.
- the yield was low, and the yield was generally low. As a result, the production cost was an obstacle to industrial scale-up.
- the method of converting the carboxyl group at the 3-position into the ester of borofluoric acid can give the target compound in a relatively high yield.
- hydrofluoric acid generated by the trifluoroborane used The harmfulness of trifluoroborane itself to humans, the corrosiveness of equipment and equipment, and the waste after reaction treatment were factors that hindered industrial manufacturing.
- the reaction process also had the disadvantage of complicated operations due to esterification and deesterification.
- the present inventors have conducted intensive studies on an excellent industrial production method to improve these drawbacks, and as a result, have found that an efficient catalyst for the 7-position nucleophilic substitution reaction of the quinolone skeleton represented by the general formula (1)
- the present invention has been completed.
- the present invention provides a compound represented by the general formula (1):
- ⁇ 2 represents a hydrogen atom, a halogen atom or a lower alkoxy group, and represents an arbitrary functional residue capable of providing a nucleophilic substitution reaction.
- X is - CH Z -, - ⁇ 4 -, shows an 0-, represents a hydrogen atom or a lower alkyl group
- Upsilon is hydrogen atom, bonded to a carbon atom arbitrary on saturated heterocyclic Or a lower alkylamino group or a group that can be easily converted to an amino group or a lower alkylamino group by chemical means, and ⁇ represents 0 or 1.
- R 5 represents a lower alkyl group, an aryl group, or a substituted aryl group, and a substituted aralkyl group
- the compound represented by the general formula (1) which is a raw material, is derived from metafluorobenzoic acids represented by the general formula (5).
- R 2 and beta 3 are as defined above, Zeta halogen atom, RS0 2 - group (R is a lower alkyl group, ⁇ rie group or a substituted ⁇ Li Lumpur group) or Shows hydroxyl group or its ester).
- Z represents a residue capable of forming a N-bond to form a quinolone ring, specifically, fluorine, chlorine, bromine, iodine, methanesulfonyl, benzenesulfonyl, p-toluenes It represents a rufonyl group, a hydroxyl group or its methyl ester, ethyl ester, etc.
- ⁇ 3 represents any functional residue capable of participating in the nucleophilic substitution reaction.
- a functional residue include fluorine, chlorine, bromine, iodine, and methyl. Tansulfonyl group, benzenesulfonyl group, ⁇ -toluenesulfonyl group.
- a compound represented by the general formula (5 ′) may be used.
- a difluoroquinocarboxylic acid ester (DFQ-ester) represented by the general formula (1 ′) derived from a suitable trifluobenzobenzoic acid chloride may be used as a raw material.
- R represents an alkyl group, an aryl group, a substituted aryl group, an aralkyl group or a substituted aralkyl group.
- Y is a hydrogen atom, a It represents a mino group or a lower alkylamino group.
- Y is a hydrogen atom, an amino group or a lower alkylamino group, or an amino group or a lower alkylamino group by ordinary chemical means. Residues that can be converted to amino groups, i.e., nitro groups, acylamino groups, and carbobenzyloxycarbonylamino groups, etc., e- nitro groups are reduced, acylamino groups are hydrolyzed, and carbobenzyl The hydroxycarbonylamino group can be easily converted to an amino group or a lower alkylamino group by reduction or hydrolysis.
- Y may be used as a precursor during the nucleophilic substitution reaction at the 7-position according to the present invention, converted into the general formula (4), and then reduced or hydrolyzed into an amino group or a lower alkyl group.
- the term "lower alkyl group j" means a straight-chain or branched-chain group having 1 to 5 carbon atoms, specifically, a methyl group, an ethyl group, an n-propyl group, an n- A tyl group, n-pentyl group and the like.
- the alkyl borate used in the present invention is represented by the general formula (3).
- B 5 represents a lower alkyl group, Ariru group, a substituted Ariru group, a ⁇ aralkyl group or a substituted Ararukiru group.
- E 5 is a methyl group, an ethyl group, an ⁇ -propyl group, an isopropyl group, an ⁇ -butyl group, a phenyl group, a 0-tolyl group, a benzyl group, and a 0-methyl phenyl group And the like.
- the compound represented by the general formula (3) may be purchased as a commercial product or may be produced from boric acid and alcohols without being separated as the general formula (3) in the reaction system. No particular restrictions.
- the reaction solvent used in the present invention is not particularly limited, but the reaction is carried out in an anhydrous manner, and the starting materials, amines, and alkyl borate are used. It is preferable to dissolve the telium by heating to raise the reaction temperature to the optimum reaction temperature, and not to reduce the activity as a Lewis acid catalyst, preferably, acetonitrile or propionite. The reaction proceeds smoothly when using lower aliphatic nitriles such as ril, ptyronitrile, and isoptyronitrile.
- the amount of the alkyl borate to be used is 0.5 to 2 moles, preferably 1 mole, of the compound represented by the formula (1).
- the reaction temperature can be optimally selected depending on the type of the starting material, the amines and the alkylborate, and the reaction is preferably carried out under heating, preferably in consideration of the added solvent and the boiling point of the alkylborate. I do. Particularly preferably, it is carried out at around 100 ° C. for several hours.
- reaction mixture is concentrated, then water or an organic solvent is added, and the pH is adjusted to obtain the desired 7-substituted quinolone carboxylic acid derivative represented by the general formula (4) in high yield.
- the compound which has been conventionally low in yield and has many problems in terms of safety, can be carried out safely and in high yield on an industrial mass scale.
- the DFQ benzyl ester (E) (1.0 g 0.026 mol) obtained in Reference Example 1 was suspended in acetonitrile (5) and uniformly dissolved by heating to 40 to 5 CTC on an oil bath. Trimethoxyborane (0.54 g, 0.052 mol) was added dropwise thereto, stirred for about 10 minutes, and suspended in acetonitrile (5). (1.19 g> O.OlOmol) was added and the mixture was refluxed for 5 hours on an oil bath. The whole was poured into water, extracted with ethyl acetate, and the ethyl acetate layer was washed with saturated saline. Dried over anhydrous MgSO 4, was separated and purified by silica Kageruka La Mukuroma preparative chromatography (5% MeOH-CHCl 3) , to give purpose was (HI) (0.10 g, 8 % yield).
- the method of the present invention for producing 6-fluoro-7-substituted-13-quinocarboxylic acids using alkylborates as catalysts solves the drawbacks of the conventional methods and achieves relatively high yields of hazardous substances.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92915777A EP0641782A1 (en) | 1991-07-16 | 1992-07-15 | Process for producing quinolonecarboxylic acid derivative |
CA002113349A CA2113349C (en) | 1991-07-16 | 1992-07-15 | Method of producing a quinolonecarboxylic acid derivative |
KR1019940700120A KR0140158B1 (ko) | 1991-07-16 | 1992-07-15 | 퀴놀론카르복실산 유도체의 제조방법 |
AU23303/92A AU657352B2 (en) | 1991-07-16 | 1992-07-15 | Process for producing quinolonecarboxylic acid derivative |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17554791 | 1991-07-16 | ||
JP3/175547 | 1991-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993002055A1 true WO1993002055A1 (en) | 1993-02-04 |
Family
ID=15997989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1992/000901 WO1993002055A1 (en) | 1991-07-16 | 1992-07-15 | Process for producing quinolonecarboxylic acid derivative |
Country Status (7)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6069157A (en) * | 1997-11-25 | 2000-05-30 | Pfizer Inc. | Parasiticidal compounds |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI362386B (en) | 2007-03-30 | 2012-04-21 | Daiichi Sankyo Co Ltd | A production method for the qunolon-carboxylic acid derivative |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59122470A (ja) * | 1982-12-27 | 1984-07-14 | Dai Ichi Seiyaku Co Ltd | キノリン−3−カルボン酸誘導体の製造法 |
JPS62252772A (ja) * | 1986-01-21 | 1987-11-04 | Kyorin Pharmaceut Co Ltd | 選択毒性に優れた8−アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4735949A (en) * | 1986-02-18 | 1988-04-05 | Warner-Lambert Company | Disubstituted-7-pyrrolidinonaphthyridine antibacterial agents |
EP0329719A1 (en) * | 1987-06-24 | 1989-08-30 | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. | Process for the preparation of quinoline carboxylic acid derivatives |
FI95130C (fi) * | 1988-07-20 | 1995-12-27 | Sankyo Co | Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi |
DE69231422T2 (de) * | 1991-05-28 | 2001-03-29 | Daiichi Pharmaceutical Co., Ltd. | Pyridoncarbonsäurederivate |
-
1992
- 1992-07-13 JP JP18540492A patent/JP3165742B2/ja not_active Expired - Fee Related
- 1992-07-15 KR KR1019940700120A patent/KR0140158B1/ko not_active Expired - Fee Related
- 1992-07-15 EP EP92915777A patent/EP0641782A1/en not_active Withdrawn
- 1992-07-15 WO PCT/JP1992/000901 patent/WO1993002055A1/ja not_active Application Discontinuation
- 1992-07-15 AU AU23303/92A patent/AU657352B2/en not_active Ceased
- 1992-07-15 CA CA002113349A patent/CA2113349C/en not_active Expired - Fee Related
- 1992-07-16 TW TW081105637A patent/TW202443B/zh active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59122470A (ja) * | 1982-12-27 | 1984-07-14 | Dai Ichi Seiyaku Co Ltd | キノリン−3−カルボン酸誘導体の製造法 |
JPS62252772A (ja) * | 1986-01-21 | 1987-11-04 | Kyorin Pharmaceut Co Ltd | 選択毒性に優れた8−アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0641782A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156782A (en) * | 1996-11-30 | 2000-12-05 | Pfizer Inc | Parasiticidal compounds |
US6069157A (en) * | 1997-11-25 | 2000-05-30 | Pfizer Inc. | Parasiticidal compounds |
Also Published As
Publication number | Publication date |
---|---|
TW202443B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-03-21 |
CA2113349A1 (en) | 1993-02-04 |
CA2113349C (en) | 2003-08-05 |
EP0641782A4 (en) | 1994-10-17 |
AU2330392A (en) | 1993-02-23 |
JP3165742B2 (ja) | 2001-05-14 |
EP0641782A1 (en) | 1995-03-08 |
JPH05294938A (ja) | 1993-11-09 |
AU657352B2 (en) | 1995-03-09 |
KR0140158B1 (ko) | 1998-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0230295B1 (en) | 8-alkoxyquinolonecarboxylic acid and salts thereof excellent in the selective toxicity and process of preparing the same | |
JP2945121B2 (ja) | 1H―イミダゾ〔4,5―c〕キノリン類の製造方法 | |
KR960002273B1 (ko) | (6,7-치환된-8-알콕시-1-사이클로프로필-1,4-디하이드로-4-옥소-3-퀴놀린카복실산-o³,o⁴)비스(아실옥시-o)보레이트, 이의 염, 이의 수화물 및 이의 제조방법 | |
JPH0541633B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
JP2532192B2 (ja) | 1−アミノ−2−フルオロシクロプロパン | |
KR870000891B1 (ko) | 퀴놀론 카복실산의 제조방법 | |
RU1838302C (ru) | Смешанные ангидриды хинолинкарбоновой кислоты и борной кислоты как промежуточные продукты дл получени производных пиперазинил-3-хинолинкарбоновой кислоты, обладающих антибактериальной активностью | |
HU199823B (en) | Process for production of derivatives of quinoline carbonic acid | |
JPH0144717B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
US5869661A (en) | Method of producing a quinolonecarboxylic acid derivative | |
JPH0768219B2 (ja) | キノリンカルボン酸の製造法 | |
WO1993002055A1 (en) | Process for producing quinolonecarboxylic acid derivative | |
US5914401A (en) | Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof | |
JPS63179856A (ja) | キノロンカルボン酸誘導体の製造方法並びにその中間体 | |
JP4305597B2 (ja) | 弗素置換安息香酸の製造法 | |
EP0216245B1 (en) | Quinolonecarboxylic acid derivatives and process for their preparation | |
JPH089598B2 (ja) | 4―オキソ―3―キノリンカルボン酸アリルエステル類 | |
JP2990903B2 (ja) | 4−オキソキノリン−3−カルボン酸類の製造方法 | |
JP3256325B2 (ja) | キノロンカルボン酸誘導体の製造方法 | |
KR920003689B1 (ko) | 퀴놀론카르복실산 유도체 및 그의 제조방법 | |
KR900001219B1 (ko) | 퀴놀린 유도체의 제조방법 | |
JPH0720940B2 (ja) | キノリン誘導体の製造法 | |
EP0195135B1 (en) | A process for the preparation of quinoline carboxylic acid derivatives | |
KR870001624B1 (ko) | 퀴롤논 유도체의 합성 방법 | |
WO1993022308A1 (en) | Process for producing quinolonecarboxylic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU KR LK LU MG MN MW NL NO PL RO RU SD SE US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
EX32 | Extension under rule 32 effected after completion of technical preparation for international publication | ||
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) | ||
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2113349 Country of ref document: CA Ref document number: 1992915777 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1994 185989 Country of ref document: US Date of ref document: 19940113 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019940700120 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1992915777 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992915777 Country of ref document: EP |